封面
市場調查報告書
商品編碼
1122385

深部腦刺激器市場規模,按應用,按最終用戶,按地區-市場規模,份額,前景和機會分析 2022-2030

Deep Brain Stimulation Devices Market size, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 110 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

腦深部刺激 (DBS) 是治療多種神經衰弱症的一部分,包括帕金森病 (PD)、癡呆症和阿爾茨海默病。使用 DBS 設備的患者可以長期緩解 PD 的衰弱症狀。一些患者在手術後可能需要藥物治療,但使用 DBS 裝置可大大減少藥物的副作用。 DBS 設備主要放置在美國食品和藥物管理局 (FDA) 批准的 PD 中三個靶點之一。最常見的靶點是內側藍斑 (GPi) 和丘腦底核 (STN)。

市場動態

新的和先進的 DBS 設備的批准和推出預計將在預測期內推動全球深部腦刺激設備市場的增長。例如,2021 年 1 月,美國醫療器械公司 Medtronic plc 啟動了一項試驗,ADAPT-PD(用於帕金森病個性化治療的自適應 DBS 算法)宣布了第一個註冊人。自適應深部腦刺激是 Percept PC 的一項研究功能,如果獲得批准,可能會變得可用。本研究中使用的研究能力將根據患者的臨床狀況自動調整大腦刺激,以提供治療以控制帕金森病症狀。

DBS 設備廣泛用於治療和管理癲癇和 PD 等疾病。因此,預計全球這些疾病的高流行將顯著增加對其管理設備的需求,從而推動全球深部腦刺激設備市場在預測期內的增長。例如,根據世界衛生組織(WHO)2019年6月公佈的數據,癲癇是一種影響各個年齡段人群的慢性非傳染性腦部疾病。全世界約有 5000 萬人患有癲癇症,這使其成為最常見的神經系統疾病之一。

本研究的主要特點

  • 本報告對全球深部腦刺激器市場進行了深入分析,提供了以 2021 年為基準年的預測期(2022-2030 年)的市場規模和復合年增長率 (CAGR %)。
  • 它還揭示了不同細分市場的潛在收入機會,並概述了一個有吸引力的市場投資建議矩陣。
  • 它還提供了重要的見解,例如市場驅動因素、限制因素、機會、新產品發布或批准、區域前景以及主要參與者採用的競爭策略。
  • 根據公司概況、業務績效、產品組合、地理分佈、分銷策略、關鍵發展和戰略以及未來計劃等參數,對全球腦部刺激市場主要參與者的概況進行分析。
  • 本研究涵蓋的主要公司包括 Boston Scientific Corporation、Medtronic, Inc.、St. Jude Medical, Inc.(雅培實驗室)、Cyber□□onics, Inc.、Neuronetics 和 Aleva Neurotherapeutics SA
  • 本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、技術升級、市場擴張和營銷策略做出明智的決策。
  • 全球深部腦刺激器市場報告迎合了該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球深部腦刺激器市場的各種策略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 報告內容
  • 市場定義和範圍
  • 執行摘要
    • 市場快照:按應用
    • 市場快照:按最終用戶分類
    • 市場概況:按地區劃分
  • 連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

  • 市場動態
    • 驅動程序
    • 限制因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要發展狀況
  • 監管場景
  • 行業趨勢
  • 新產品批准/發布
  • 併購
  • 技術進步
  • 流行病學/流行率/發病率
  • 促銷和營銷工作

第 4 章全球深部腦刺激器市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • COVID-19 對市場的影響

第 5 章全球深部腦刺激器市場:按應用,2017-2030 年

  • 帕金森病
  • 特發性震顫
  • 肌張力障礙
  • 其他

第 6 章全球深部腦刺激器市場:按最終用戶,2017-2030 年

  • 醫院和診所
  • 門診手術中心
  • 其他

第 7 章全球深部腦刺激器市場,按地區,2017-2030 年

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 澳大利亞
  • 韓國
  • 其他亞太地區
  • 中東
  • 海合會
  • 以色列
  • 其他中東
  • 非洲
  • 北非
  • 中非
  • 南非

第 8 章競爭格局

  • 熱圖分析
  • 公司簡介
    • Boston Scientific Corporation
    • Medtronic, Inc.
    • St. Jude Medical, Inc.(Abbott Laboratories)
    • Cyberonics, Inc.
    • Neuronetics
    • Aleva Neurotherapeutics SA.

第九章章節

  • 參考資料
  • 調查方法介紹
  • 關於出版商
簡介目錄
Product Code: CMI84

Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson's disease (PD), dementia, and Alzheimer's disease. A patient fitted with a DBS device can get long-term relief from debilitating symptoms of PD. Although, some patients may require medications post-surgery, there is significant reduction in side-effects caused due to medications, owing to use of DBS devices. A DBS device is mainly placed in one of the three U.S. Food and Drug Administration (FDA) approved target sites in PD. Most commonly preferred target sites are the Globus Pallidus Interna (GPi) and Subthalamic Nucleus (STN).

Market Dynamics

Approval and launch of novel and advanced DBS devices is expected to drive the global deep brain stimulation devices market growth over the forecast period. For instance, in January 2021, Medtronic plc, a U.S. based medical device company, announced the first enrollment in ADAPT-PD (Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson's Disease (PD). Adaptive deep brain stimulation is an investigational feature of the Percept PC device that could be enabled if approved. The investigational feature used in this study allows for automated adjustment of brain stimulation to provide therapy to manage symptoms of Parkinson's disease based on a patient's clinical state.

DBS devices are widely used in the treatment and management of diseases such as epilepsy and PD. Therefore, high prevalence of these diseases worldwide is expected to drastically increase demand for its management devices, thereby driving the global deep brain stimulation devices market growth over the forecast period. For instance, according to the data published by the World Health Organization (WHO) in June 2019, epilepsy is a chronic non-communicable disease of the brain that affects people of all ages. Globally, around 50 million people suffer from epilepsy, making it one of the most common neurological diseases.

Key features of the study:

  • This report provides an in-depth analysis of the global deep brain stimulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2030), considering 2021, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global deep brain stimulation devices market based on following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include, Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global deep brain stimulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global deep brain stimulation devices market

Detailed Segmentation:

  • Global Deep Brain Stimulation Device Market, By Application:
    • Parkinson's Disease
    • Essential Tremor
    • Dystonia
    • Others
  • Global Deep Brain Stimulation Device Market, By End User:
    • Hospital & Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Deep Brain Stimulation Device Market, By Region:
    • North America
      • By country
    • U.S.
    • Canada
    • Europe
      • By Country
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Boston Scientific Corporation.*
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Medtronic, Inc.
    • Jude Medical, Inc. (Abbott Laboratories)
    • Cyberonics, Inc.
    • Neuronetics
    • Aleva Neurotherapeutics SA.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By End Users
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Industry Trend
  • New Product Approvals/Launch
  • Merger and Acquisitions
  • Technological Advancement
  • Epidemiology/Prevalence/Incidence
  • Promotion and Marketing Initiatives

4. Global Deep Brain Stimulation Devices Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • COVID-19 Impact on the market

5. Global Deep Brain Stimulation Devices Market, By Application, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Parkinson Disease
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Essential Tremor
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Dystonia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Deep Brain Stimulation Devices Market, By End User,2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017- 2030
    • Segment Trends
  • Hospitals and Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Deep Brain Stimulation Devices Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profile
    • Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Medtronic, Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • St. Jude Medical, Inc. (Abbott Laboratories)
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Cyberonics, Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Neuronetics
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Aleva Neurotherapeutics SA.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us